NVCT stock jumped after Nuvectis expanded its pipeline through a licensing deal with Haisco.
Nuvectis Pharma, Inc. (NASDAQ:NVCT) shares are trending on Monday.
NVCT shares surged 19.61% during Monday’s regular trading session to close at $16.53.
The stock slipped slightly in after-hours trading, falling 2.90% to $16.05.
Nuvectis Pharma is a clinical-stage biopharmaceutical company developing treatments for complement-related diseases and cancer.
Its pipeline includes NXP100, a complement Factor B inhibitor, and cancer drug candidates NXP900 and NXP200.
Nexentis stock surged on AI drug discovery news before falling after announcing a $2.9 million offering.
GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT, MTEN, NCRA, ZTG, EPSM, DBI,…
Navitas stock rises as tech strength supports NVTS, while investors watch its NVIDIA AI power update and dilution concerns.
SHELTON, CT / ACCESS Newswire / May 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) ("NanoViricides" or the "Company"), a…
Navan ($NAVN) stock surges 18%+ in premarket trading after crushing Q1 earnings estimates and raising its full-year 2027 outlook.
Navitas Semiconductor shares are trading higher Wednesday after announcing a new collaboration tied to next-gen AI data-center…
